17/05/2018 Guerbet strengthens its leadership in innovative interventional radiology with the launch of two new microcatheters
Guerbet strengthens its leadership in innovative interventional radiology with the launch of two new microcatheters
Gadolinium-based contrast agents: update from Guerbet LLC on U.S. Food and Drug Administration (FDA) requirements
24/10/2017 FDA Approves Guerbet’s Dotarem® (gadoterate meglumine) for Pediatric Patients Younger Than Two Years
Princeton (NJ, USA), September 5, 2017 Guerbet LLC USA, the US affiliate of the global specialist in contract products and solutions for medical imaging, announced today that the US Food and Drug Administration (FDA) has approved Dotarem® (gadoterate meglumine) for intravenous use with magnetic...
Princeton (NJ, USA) Magnetic resonance imaging (MRI) is a widely used diagnostic procedure which is critical to patient health. And vital to MRI are the contrast agents that give physicians a sharper, more accurate picture of tissue than they would otherwise be able to have. There are two...
Princeton, NJ, 23 June 2016 – Guerbet announced that it has been named a winner of Premier Inc.’s Supplier Horizon Award
Guerbet LLC, USA (September 29, 2014)